Profiles for companies starting with 'k'
✉ Email this page to a colleague
Drugs and US Patents for k
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Karo Hlthcare | LAMISIL | terbinafine | GEL;TOPICAL | 020846-001 | Apr 29, 1998 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Karyopharm Theraps | XPOVIO | selinexor | TABLET;ORAL | 212306-001 | Jul 3, 2019 | RX | Yes | No | 10,519,139 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Kaleo Inc | AUVI-Q | epinephrine | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 201739-003 | Nov 17, 2017 | RX | Yes | No | 11,590,286 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Kai Pharms Inc | PARSABIV | etelcalcetide | SOLUTION;INTRAVENOUS | 208325-001 | Feb 7, 2017 | RX | Yes | Yes | 8,999,932 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Kaleo Inc | EVZIO | naloxone hydrochloride | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS | 205787-001 | Apr 3, 2014 | DISCN | Yes | No | 9,474,869 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Kowa Pharms | SEGLENTIS | celecoxib; tramadol hydrochloride | TABLET;ORAL | 213426-001 | Oct 15, 2021 | DISCN | Yes | No | 10,245,276 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
